Abstract
Cerebral palsy (CP) is a relatively prevalent condition, with an incidence of 1.7 to 3.1 per 1000 live births in high income countries, with higher incidence in low income countries. CP is the most common cause of physical disability in children. Advances in intervention options have been remarkable in recent decades, including botulinum neurotoxin type A (BoNT-A) and intrathecal baclofen…